In this issue of Angiology, Shannon et al compared 30-day major adverse limb events (MALEs) and 30-day major adverse cardiac events (MACEs) in patients with prior failed ipsilateral endovascular intervention undergoing repeat endovascular intervention versus lower extremity bypass. 1 Although MALEs did not differ between the 2 groups, MACEs were considerably lower after repeat endovascular intervention (2.2%) compared to lower extremity bypass either with a single segment saphenous vein (5.8%) or with an alternative (prosthetic, spliced vein or composite) conduit (6.7%; for both comparisons, P < .001). 1 The authors conclude that repeat endovascular intervention should be the preferred treatment for repeat revascularization when anatomy is amenable. 1 This Editorial considers some additional aspects regarding this topic.
Repeat Angioplasty: Is It Durable?
The potential lack of durability of endovascular interventions is an important drawback of these procedures compared to lower extremity bypass. An earlier study (mentioned by the authors) 1 reported the results of second-time femoropopliteal percutaneous transluminal angioplasty/stenting in patients with a failed initial endoluminal intervention. 2 Reintervention was technically successful in 97% of the patients with low rates of intraprocedural (10%) and postprocedural (4%) complications. Furthermore, 87% of the patients had initial clinical improvement. Nevertheless, 2-year primary patency, secondary patency, limb salvage, and survival rates were 33% + 7%, 63% + 7%, 87% + 9%, and 88% + 5%, respectively. 2 Repeat endovascular intervention within 180 days of the initial endovascular procedure was the only significant predictor of failure of primary (hazard ratio [HR] ¼ 2.65; 95% confidence interval [CI] ¼ 1.4-5.2; P ¼ .0029) and secondary (HR ¼ 3.1; 95% CI ¼ 1.4-7.1; P ¼ .0049) patency of the repeat procedure. The authors supported that although a repeat endovascular procedure had excellent initial technical success and low morbidity, the midterm results are not encouraging and in fact, repeat endovascular intervention is not effective in establishing durable patency after an initial failed endovascular procedure. The authors concluded that after early endovascular failure, alternatives to a continued endovascular approach should be adopted. 2 In a study from New York, 3 246 patients (251 limbs) undergoing infrainguinal percutaneous transluminal angioplasty with or without stenting were followed up for a mean period of 11.8 (range: 0-51) months. Percutaneous interventions were immediately successful in 97% of the patients. In 46 (18%) patients, the endovascular intervention failed. Of these, 4.3% (n ¼ 2) failed in the first 30 days, 78.2% (n ¼ 36) failed between 1 and 18 months, and 17.5% (n ¼ 8) failed following 18 months, with a mean time to failure of 8.7 months. All failures were due to restenosis or occlusion at the site of primary intervention. 3 The potential lack of durability and the higher incidence of restenosis of endovascular interventions compared to lower extremity bypass are counterbalanced with the lower morbidity rates associated with endovascular procedures. A study from Texas compared the outcomes of superficial femoral artery (SFA) angioplasty versus bypass in patients requiring a repeat intervention for SFA restenosis following an initial endovascular treatment. 4 A total of 735 limbs in 631 patients underwent endovascular treatment for symptomatic SFA disease (61% for lifestyle-limiting claudication). The restenosis was 16% + 3% at 5 years (n ¼ 222 patients). Of these, 58 remained asymptomatic whereas 164 underwent repeat interventions, either repeat endovascular intervention (n ¼ 96 patients) or bypass (n ¼ 68 patients). The 5-year freedom from recurrent symptoms was superior in the bypass group compared to the repeat endovascular group (80% + 7% vs 63% + 9%, respectively; P ¼ .03). The repeat bypass group had higher immediate symptom relief, these resolving in 60% and improving in 35% of the patients compared to 28% and 28% for repeat endovascular intervention, respectively (P < .0001). 4 In contrast, repeat endovascular intervention was associated with lower morbidity rates compared to bypass (16% vs 28%, respectively; P ¼ .04).
According to the recent Guidelines of the European Society of Cardiology and the European Society for Vascular Surgery, an endovascular-first strategy is recommended for short (ie, <25 cm lesions) femoropopliteal occlusive lesions (Class I; Level of evidence: C). 5 In contrast, a bypass is recommended for long (ie, >25 cm) SFA lesions in patients who are not at high risk for surgery when an autologous vein is available and the patient's life expectancy is >2 years (Class: I; Level of Evidence: B). 5 In cases of failed endovascular interventions, however, there is not a clear recommendation regarding repeat endovascular intervention versus bypass.
The Trans-Atlantic Society Consensus (TASC) II classification has been traditionally used to characterize lesions in the lower limb arteries. 6 There is evidence that patients with advanced infrainguinal occlusive disease (TASC C/D lesions) would likely benefit from open surgical bypass over an endovascular intervention. 6, 7 Compared to lower extremity bypasses, endovascular interventions are associated with lower morbidity rates at the expense of higher cost and higher amputation rates. 8 Endovascular interventions have reduced technical success and durability compared to bypass surgery, but the clinical benefit is acceptable for frail patients at high risk for surgery. [9] [10] [11] Restenosis rates are also higher with endovascular interventions compared to bypass. [9] [10] [11] A bypass using autologous vein results in better limb salvage rates compared to endovascular procedures in patients with tissue loss. [9] [10] [11] An important issue to consider is that failure of endovascular procedures may result in the thrombus extending beyond the level of the initial stenosis on a segment of previously patent artery. This makes a bypass procedure more complex as a more distal bypass has to be done. An earlier study from South Carolina looked into the outcomes of 276 patients who underwent endovascular intervention of the SFA. 12 Early failure was noted in 24 limbs. The distal bypass site was altered in 6 limbs (28.6%): in 4 from popliteal to tibial and in another 2 from above-to below-knee popliteal. 12 A more distal bypass has lower patency rates and is a more complex and lengthy procedure. 6, 7 One of the limitations of the study by Shannon et al (mentioned by the authors) 1 is that it only assessed early (30-day) outcomes after repeat intervention. It would be interesting to know the long-term (eg, 1-or 2-year) primary and secondary patency rates of the repeat interventions and if their conclusion would still be the same. Although repeat angioplasty may be successful in some patients, the uncertainty about the long-term durability of endovascular procedures may be the reason to explore a surgical alternative.
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